Caricamento della pagina

blog.fallback_notice_title
blog.fallback_notice_body
blog.tldr_label
What really makes Xeomin different from Botox, when the protein-free formulation matters, and how brand choice should be made in practice.
blog.key_takeaways
Xeomin is often marketed as the pure form of botulinum toxin because it lacks complexing proteins around the active neurotoxin. That technical distinction can matter in selected patients, but it is not a magic shortcut to a better face.
For many patients, Botox and Xeomin can both work very well when diagnosis, dose, and injection planning are sound.
Natural results depend far more on anatomy and dosing than on brand slogans. Xeomin may be strategically useful in long-term toxin users or in patients where secondary resistance is a concern, but not every patient needs to switch.
A good consultation should focus on treatment history, previous response, duration, and goals rather than on simplistic claims that one brand is always stronger or more natural.
DailyMed / FDA label · drug label · 4 mar 2026
PubMed · review · 1 set 2024
PubMed · review · 5 mar 2015

Trusted & Professional
Dr. Hamza Gemici is a medical aesthetic physician based in Ataşehir, Istanbul. His practice focuses on natural anti-aging and subtle facial harmonization using botulinum toxin, dermal fillers, periocular rejuvenation and skin quality procedures. All treatments are performed with FDA-approved products under physician-guided protocols.